JULIE CARROLL: Open Payments
NPI 1316601628 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,053 in 124 payments from 18 companies in 2025. Trend: 2023 $302 · 2024 $2,919 · 2025 $3,053
Food & beverage: $2,941Education: $112
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $547 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $433 |
| Regeneron Healthcare Solutions, Inc. | 12 | $368 |
| UCB, Inc. | 11 | $357 |
| Novartis Pharmaceuticals Corporation | 13 | $315 |
| E.R. Squibb & Sons, L.L.C. | 17 | $314 |
| Galderma Laboratories, L.P. | 9 | $189 |
| Janssen Biotech, Inc. | 7 | $144 |
| GENZYME CORPORATION | 4 | $94 |
| Lilly USA, LLC | 4 | $80 |
Products named: DUPIXENT, ILUMYA, Bimzelx, Sotyktu, RINVOQ, SKYRIZI, COSENTYX, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
